WeChat Mini Program
Old Version Features

Brigatinib Monotherapy in Children with R/R ALK+ ALCL, IMT, or Other Solid Tumors: Results from the BrigaPED (ITCC-098) Phase 1 Study.

Journal of Clinical Oncology(2024)

Cited 0|Views18
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined